Meta Biomed Co. Ltd (059210) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Meta Biomed Co. Ltd (059210) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.05 Billion ≈ $714.42K USD) by net assets (₩121.24 Billion ≈ $82.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 059210 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Meta Biomed Co. Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Meta Biomed Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Meta Biomed Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Meta Biomed Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
AFC Gamma Inc NASDAQ:AFCG	-0.003x
Global Mofy Metaverse Limited Ordinary Shares NASDAQ:GMM	0.193x
Emc Gold Corporation AU:EM3	-0.137x
IB Acquisition Corp. Common Stock NASDAQ:IBAC	-0.069x
Microcosm Technology Co Ltd TWO:3354	-0.025x
PUBLIC POLICY HO.COM 144A F:PD7	N/A
Kredyt Inkaso SA WAR:KRI	0.105x
Evertex Fabrinology Ltd TW:1470	0.041x

Annual Cash Flow Conversion Efficiency for Meta Biomed Co. Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Meta Biomed Co. Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see Meta Biomed Co. Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩93.34 Billion ≈ $63.25 Million	₩22.63 Billion ≈ $15.34 Million	0.242x	+72.44%
2023-12-31	₩72.66 Billion ≈ $49.24 Million	₩10.22 Billion ≈ $6.92 Million	0.141x	-6.98%
2022-12-31	₩60.59 Billion ≈ $41.06 Million	₩9.16 Billion ≈ $6.21 Million	0.151x	-20.83%
2021-12-31	₩58.32 Billion ≈ $39.52 Million	₩11.14 Billion ≈ $7.55 Million	0.191x	+88.43%
2020-12-31	₩47.98 Billion ≈ $32.51 Million	₩4.86 Billion ≈ $3.29 Million	0.101x	+88.40%
2019-12-31	₩53.27 Billion ≈ $36.10 Million	₩2.86 Billion ≈ $1.94 Million	0.054x	+150.87%
2018-12-31	₩49.97 Billion ≈ $33.86 Million	₩-5.28 Billion ≈ $-3.58 Million	-0.106x	-1857.36%
2017-12-31	₩46.01 Billion ≈ $31.18 Million	₩-248.51 Million ≈ $-168.41K	-0.005x	-105.54%
2016-12-31	₩51.59 Billion ≈ $34.96 Million	₩5.03 Billion ≈ $3.41 Million	0.098x	+0.59%
2015-12-31	₩50.87 Billion ≈ $34.47 Million	₩4.93 Billion ≈ $3.34 Million	0.097x	+1547.11%
2014-12-31	₩44.20 Billion ≈ $29.96 Million	₩-296.24 Million ≈ $-200.76K	-0.007x	-108.04%
2013-12-31	₩44.54 Billion ≈ $30.18 Million	₩3.71 Billion ≈ $2.52 Million	0.083x	-11.04%
2012-12-31	₩40.89 Billion ≈ $27.71 Million	₩3.83 Billion ≈ $2.60 Million	0.094x	-10.84%
2011-12-31	₩39.05 Billion ≈ $26.46 Million	₩4.10 Billion ≈ $2.78 Million	0.105x	--

About Meta Biomed Co. Ltd

KQ:059210 Korea Healthcare Equipment & Supplies

Market Cap

$61.85 Million

₩91.27 Billion KRW

Market Cap Rank

#21123 Global

#1199 in Korea

Share Price

₩3885.00

Change (1 day)

+1.83%

52-Week Range

₩3385.00 - ₩6520.00

All Time High

₩6954.44